|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/28 |
| (11) | Patento numeris | 2277543 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10010884.4 |
| Europos patento paraiškos padavimo data | 2003-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-01-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 408719 P | 2002-09-06 | US |
| (72) |
Huang, Haichun, US
Varnum, Brian, US
Vezina, Chris, US
Witte, Alison, US
Qian, Xueming, US
Martin, Frank, US
Elliott, Gary, US
|
| (73) |
Amgen, Inc,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road, Princeton, NJ 08540, US |
| (54) | Therapeutic anti-IL-1R1 monoclonal antibody |
| Therapeutic anti-IL-1R1 monoclonal antibody |